Page last updated: 2024-10-25

citalopram and 2019 Novel Coronavirus Disease

citalopram has been researched along with 2019 Novel Coronavirus Disease in 7 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's7 (100.00)2.80

Authors

AuthorsStudies
Oskotsky, T1
Maric, I1
Tang, A1
Oskotsky, B1
Wong, RJ1
Aghaeepour, N1
Sirota, M1
Stevenson, DK1
Tronco Pauletto, PJ1
Omage, FB1
Delgado, CP1
Nogara, PA1
Teixeira Rocha, JB1
Boogaerts, T1
Quireyns, M1
De Loof, H1
Bertels, X1
Van Wichelen, N1
Pussig, B1
Saevels, J1
Lahousse, L1
Bonmariage, P1
Hamelinck, W1
Aertgeerts, B1
Covaci, A1
van Nuijs, ALN1
Visos-Varela, I1
Zapata-Cachafeiro, M1
Piñeiro-Lamas, M1
Carracedo-Martínez, E1
Saez, M1
Herdeiro, MT1
Figueiras, A1
Salgado-Barreira, Á1
Uvais, NA1
Audley, GG1
Frankenfeld, P1
Dlamini, S1
Raubenheimer, P1
Hoare, J1
Cairncross, L1
Van den Berg, R1
Gule, MV1
Calligaro, G1
Burstein, O1
Simon, N1
Simchon-Tenenbaum, Y1
Rehavi, M1
Franko, M1
Shamir, A1
Doron, R1

Other Studies

7 other studies available for citalopram and 2019 Novel Coronavirus Disease

ArticleYear
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
    JAMA network open, 2021, 11-01, Volume: 4, Issue:11

    Topics: Adult; Aged; Antidepressive Agents; Citalopram; COVID-19; Cytokines; Female; Fluoxetine; Fluvoxamine

2021
    Current drug discovery technologies, 2023, Volume: 20, Issue:2

    Topics: Antidepressive Agents; Antiviral Agents; Citalopram; COVID-19; Fluoxetine; Humans; Molecular Docking

2023
Do the lockdown-imposed changes in a wastewater treatment plant catchment's socio-demographics impact longitudinal temporal trends in psychoactive pharmaceutical use?
    The Science of the total environment, 2023, Jun-10, Volume: 876

    Topics: Biomarkers; Citalopram; Communicable Disease Control; COVID-19; Demography; Desvenlafaxine Succinate

2023
Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2023, Volume: 71

    Topics: Case-Control Studies; Citalopram; COVID-19; Drug Repositioning; Humans; SARS-CoV-2; Selective Seroto

2023
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
    The primary care companion for CNS disorders, 2020, 06-25, Volume: 22, Issue:4

    Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Ci

2020
Prolonged treatment of COVID-19 pneumonia with high-flow nasal oxygen: A story of oxygen and resilience.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2020, 10-08, Volume: 110, Issue:12

    Topics: Anti-Bacterial Agents; Anticoagulants; Anxiety; Blood Gas Analysis; Cannula; Citalopram; Counseling;

2020
Moderation of the transgenerational transference of antenatal stress-induced anxiety.
    Translational psychiatry, 2021, 05-04, Volume: 11, Issue:1

    Topics: Animals; Anxiety; Citalopram; COVID-19; Crataegus; Disease Models, Animal; Drugs, Chinese Herbal; Fe

2021